Table 2.
Questionnaire results
| All patients
|
Untreated SBRD
|
Treated SRBD
|
PLMD/RLS
|
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All | M | F | All | M | F | All | M | F | All | M | F | |
| Number | 410 | 290 | 120 | 231 | 176 | 55 | 102 | 80 | 22 | 19 | 6 | 13 |
| % | 100 | 70.7 | 29.3 | 56.3 | 42.9 | 13.4 | 24.9 | 19.5 | 5.4 | 4.7 | 1.5 | 3.2 |
| MFIS2 | ||||||||||||
| Mean | 32.4 | 30.1 | 38.0 | 32.5 | 31.9 | 35.8 | 28.8 | 24.2 | 45.5 | 44.1 | 32.2 | 48.6 |
| SEM | 1.0 | 1.2 | 1.7 | 1.0 | 1.3 | 1.8 | 1.0 | 1.3 | 1.8 | 1.0 | 1.6 | 1.8 |
| 25%–75% | 15–49 | 12.0–45.0 | 23.8–52.0 | 16–47.5 | 15.0–45.3 | 22.0–49.0 | 10–45.5 | 5.5–40.5 | 31.5–56.3 | 31.8–55.8 | 23.0–57.0 | 40.5–60.5 |
| FSS4 | ||||||||||||
| Mean | 4.0 | 3.7 | 4.6 | 4.1 | 4.1 | 4.2 | 3.5 | 3.1 | 5.0 | 4.5 | 4.0 | 4.5 |
| SEM | 0.1 | 0.1 | 0.2 | 1.1 | 0.1 | 0.2 | 1.1 | 0.1 | 0.2 | 0.1 | 0.1 | 1.2 |
| 25%–75% | 2.2–5.7 | 2.0–5.2 | 3.1–6.2 | 2.2–5.7 | 2.2–5.7 | 2.4–5.9 | 2.0–5.0 | 1.6–4.4 | 3.8–6.7 | 3.9–5.8 | 2.8–5.2 | 3.1–5.8 |
| ESS20 | ||||||||||||
| Mean | 8.4 | 8.3 | 8.7 | 8.7 | 8.5 | 9.1 | 7.3 | 7.4 | 7.0 | 9.9 | 7.8 | 7.6 |
| SEM | 0.3 | 0.4 | 0.5 | 0.4 | 0.5 | 0.5 | 0.7 | 0.6 | 3.4 | 1.4 | 0.4 | 0.5 |
| 25%–75% | 5–11 | 4.3–11.0 | 5.0–11.0 | 5–12 | 5.0–11.0 | 5.0–12.8 | 4–10 | 3.8–10.3 | 3.5–9.0 | 7–13.5 | 1.8–11.8 | 5.0–10.0 |
| PSQI24 | ||||||||||||
| Mean | 8.2 | 7.6 | 10.0 | 8.2 | 7.9 | 9.8 | 6.7 | 6.3 | 8.4 | 11.4 | 10.2 | 12.3 |
| SEM | 1.0 | 0.3 | 0.5 | 0.3 | 0.3 | 0.5 | 0.3 | 0.3 | 0.5 | 0.3 | 0.4 | 0.1 |
| 25%–75% | 5–12 | 4.0–11.0 | 6.0–13.0 | 5–11 | 4.0–11.0 | 7.0–13.0 | 4–10 | 3.0–8.0 | 5.0–12.0 | 8–15 | 6.5–15.0 | 9.0–15.0 |
| Insomnia
|
Parasomnia
|
Hypersomnia narcolepsy, myasthenia
|
No sleep disorder
|
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All | M | F | All | M | F | All | M | F | All | M | F | |
| Number | 22 | 6 | 16 | 3 | 2 | 1 | 13 | 8 | 5 | 20 | 12 | 8 |
| % | 5.4 | 1.5 | 3.9 | 0.7 | 0.5 | 0.2 | 3.1 | 2.0 | 1.2 | 4.9 | 2.9 | 2.0 |
| MFIS2 | ||||||||||||
| Mean | 33.5 | 38.7 | 31.5 | 7.7 | 2.0 | 19.0 | 40.6 | 42.5 | 37.6 | 26.1 | 19.8 | 34.8 |
| SEM | 1.1 | 1.4 | 1.8 | 1.6 | 2.2 | 0.0 | 1.1 | 1.2 | 2.2 | 1.1 | 1.6 | 1.9 |
| 25%–75% | 15–47.5 | 13.8–56.3 | 15.0–44.0 | 0.0–19.0 | 0.0–4.0 | 19.0–19.0 | 22.3–57.5 | 29.3–54.5 | 12.0–62.0 | 5–47 | 0.0–34.0 | 16.3–51.8 |
| FSS4 | ||||||||||||
| Mean | 4.3 | 4.0 | 4.5 | 2.2 | 1.4 | 4.0 | 5.2 | 5.2 | 5.2 | 3.6 | 2.9 | 5.2 |
| SEM | 1.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.0 | 0.1 | 0.1 | 0.2 | 1.1 | 0.2 | 0.2 |
| 25%–75% | 2.9–5.8 | 2.8–5.2 | 3.1–5.8 | 1.1–4.0 | 1.1–1.6 | 4.0–4.0 | 3.7–6.6 | 3.7–6.4 | 2.8–6.7 | 1.0–5.0 | 1.0–4.1 | 3.8–6.6 |
| ESS20 | ||||||||||||
| Mean | 7.7 | 7.8 | 7.6 | 3.0 | 3.0 | 3.0 | 12.7 | 11.6 | 15.3 | 8.9 | 8.4 | 9.5 |
| SEM | 0.8 | 0.4 | 0.1 | 0.7 | 0.6 | 0.0 | 1.3 | 0.4 | 0.3 | 1.1 | 0.5 | 0.1 |
| 25%–75% | 4–10 | 1.8–11.8 | 5.0–10.0 | 2.0–4.0 | 2.0–4.0 | 3.0–3.0 | 7.8–16.0 | 7.0–16.0 | 14.0–16.0 | 7.0–10.5 | 7.0–9.5 | 4.0–14.0 |
| PSQI24 | ||||||||||||
| Mean | 13.2 | 13.3 | 13.1 | 4.5 | 3.0 | 6.0 | 10.6 | 12.0 | 5.0 | 7.9 | 7.1 | 8.8 |
| SEM | 0.3 | 0.3 | 0.5 | 0.4 | 0.1 | 0.0 | 0.3 | 0.3 | 0.0 | 0.3 | 0.4 | 0.5 |
| 25%–75% | 11–15 | 13.0–14.0 | 11.0–15.0 | 3.0–6.0 | 3.0–3.0 | 6.0–6.0 | 7.0–14.5 | 9.3–15.3 | 5.0–5.0 | 5.0–11.3 | 4.3–11.5 | 5.0–12.5 |
Abbreviations: ESS, Epworth Sleepiness Scale; FSS, Fatigue Severity Scale; MFIS, Modified Fatigue Impact Scale; PLMD, periodic limb movement disorder; PSQI, Pittsburgh Sleep Quality Index; RLS, restless legs syndrome; SEM, standard error of the mean; SpO2% min, minimal desaturation; SRBD, sleep-related breathing disorder; F, female; M, male.